The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2018 | Geriatric oncology: immunotherapy for elderly patients with lymphoma
The European Hematology Association (EHA) Scientific Working Group on Aging and Hematology released a new edition about geriatric oncology. Here, Raúl Córdoba, MD, PhD, from the Fundacion Jimenez Diaz University Hospital, Madrid, Spain, discusses reviewing the edition’s safety and efficacy data on immunotherapy for treating elderly patients with lymphoma. While patient enrollment was low, meaning that results are inconclusive, there are positive signs of treatment efficacy. Speaking at the 23rd Congress of the European Hematology Association (EHA) 2018, held in Stockholm, Sweden, Dr Córdoba points out that there are increased cases of adverse immune response events in older patients, and therefore closer monitoring is required.
